Columbia Financ SEC Filings

John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK), reported a purchase on 09/19/2025 of 41.1644 phantom stock units at $15.51 under the Columbia Bank Stock Based Deferral Plan, which will be settled in shares upon distribution. The filing shows indirect beneficial ownership categories including 7,848.6975 shares held indirectly and several plan-based holdings: 60,769 shares (disposed), 17,130 via 401(k), 7,620 via ESOP, 7,051 via SERP, 4,214 via SIM, and multiple stock awards totaling 39,672 shares across award tranches. Klimowich also holds exercisable stock options totaling 229,425 options across four grants with exercise prices from $15.60 to $16.49.

Form 4 filed for Columbia Financial, Inc. (CLBK) shows Jenifer Walden White, listed as an EVP & CHRO and director, reporting stock and option holdings and an acquisition on 09/19/2025. The filing reports an acquisition of 34.345 phantom stock units at a reported price of $15.51 under the Companys stock-based deferral plan. Following the transaction, the filing lists total beneficial ownership components across direct and indirect holdings, including 3,352 shares direct, multiple indirect holdings via ESOP, SERP, SIM and several stock awards, and 2,809.7786 units reported as indirect beneficial ownership after the acquisition. The report also discloses outstanding stock options exercisable into 5,540, 6,203, 5,107 and 11,297 shares with exercise prices of $20.54, $15.94, $16.49 and $16.23, respectively.

Allyson Katz Schlesinger, SEVP & Head of Consumer Banking at Columbia Financial, Inc. (CLBK), reported transactions on 09/19/2025. The filing shows an acquisition of 21.5744 phantom stock units under the Columbia Bank Stock Based Deferral Plan at a price of $15.51 per share equivalent, which will be settled in shares upon distribution. The form also reports a disposition of 64,281 common shares. The report lists multiple indirect holdings across the reporting person’s benefit plans and awards, and several outstanding stock options with exercise prices from $15.60 to $16.49 and expirations through 2035.

Jennings William Justin, EVP, Operations Officer of Columbia Financial, Inc. (CLBK), reported multiple equity-related transactions and holdings. On 09/19/2025 he acquired 48.3559 phantom stock units under the Bank's rabbi trust for the Stock Based Deferral Plan at a reported price of $15.51, which will be settled in shares upon distribution. The reporting person also discloses existing indirect and direct holdings across plans and awards: 11,754 shares disposed, and beneficial ownership interests including 3,116 shares (ESOP), 608 shares (SERP), and vested and unvested stock awards and options totaling ~80,292 underlying shares/options across several grants and expirations.

Thomas J. Kemly, President & CEO and director of Columbia Financial, Inc. (CLBK), reported insider transactions dated 09/19/2025 on a Form 4. The filing shows an acquisition under the Columbia Bank Stock Based Deferral Plan described as 115.2244 units purchased at $15.51 (noted as phantom stock to be settled in shares). The filing lists multiple existing direct and indirect common stock holdings and awards, including a reported post-transaction beneficial ownership amount of 65,670.89 (I). The report also discloses outstanding stock options exercisable into common shares with strike prices and amounts: $15.60 (656,471), $15.94 (37,894), $16.49 (37,168), and $16.23 (94,749). Explanations clarify vesting schedules and that certain awards are performance-based or subject to multi-year vesting.

Columbia Financial, Inc. (CLBK) Form 4 highlights insider transactions by EVP Operations Officer William Jennings. The filing shows a non-derivative acquisition on 09/05/2025 of 49.9666 phantom stock units purchased at $15.01 under the Columbia Bank Stock Based Deferral Plan; those units will be settled in shares upon distribution. The report also discloses existing beneficial holdings across plans: an ESOP holding of 3,116 shares, a SERP holding of 608 shares, and stock awards identified as 7,795 and 7,533 shares tied to performance and time-based vesting. Derivative holdings include stock options for 41,475, 5,715, and 13,051 underlying shares with exercise prices of $21.79, $16.49, and $16.23, respectively; the largest option tranche is fully vested and exercisable.

Insider purchase and holdings summary for Columbia Financial, Inc. (CLBK): On 09/05/2025, Jenifer White (EVP & CHRO) was reported to have acquired 35.489 units of common stock at a price of $15.01 under the Columbia Bank Stock Based Deferral Plan, with settlement to be made in shares upon distribution. The filing lists multiple classes of her current beneficial ownership across plans and awards, including direct holdings and indirect holdings through an ESOP, SERP, SIM and several stock award tranches.

The report also discloses outstanding stock options exercisable into common stock: 5,540 options at $20.54 (exp. 10/31/2032), 6,203 at $15.94 (exp. 05/01/2033), 5,107 at $16.49 (exp. 03/06/2034), and 11,297 at $16.23 (exp. 03/03/2035). The Form 4 was signed by a power of attorney on 09/09/2025.

Holland Noel R., a director of Columbia Financial, Inc. (CLBK), reported transactions on Form 4 dated 09/05/2025. The filing shows the trustee of the Bank's rabbi trust purchased 11.0995 phantom stock units at $15.01 under the Columbia Bank Stock Based Deferral Plan; those units will be settled in shares upon distribution. The report lists multiple holdings: 9,968.4445 shares indirectly held via the deferral plan, 46,280 shares indirectly held in a SEP-IRA, and 3,207 shares indirectly from a stock award. The filer also reported a disposition of 33,519 common shares.

The filer holds fully vested stock options83,294 underlying common shares held directly. Stock awards granted under the 2019 Equity Incentive Plan will vest on 03/11/2026.

John Klimowich, SEVP & Chief Risk Officer of Columbia Financial, Inc. (CLBK) reported transactions dated 09/05/2025 on a Form 4. The filing shows a non-derivative acquisition on 09/05/2025 of 42.5356 shares at $15.01. The table lists various categories of beneficial ownership following the reported transactions, including 7,807.5331 shares held indirectly and other plan-based and award-based indirect holdings (for example, 60,769, 17,130, 7,620, 7,051, 4,214, 13,781, 12,068, 11,723). Derivative holdings show stock options totaling 229,425 options across four option grants with exercise prices of $15.60, $15.94, $16.49, and $16.23, with expiration dates through 2035.